𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Myasthenia gravis in the tenth decade

✍ Scribed by Lawrence H. Phillips II; Vern C. Juel


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
159 KB
Volume
22
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Plasmapheresis in myasthenia gravis
✍ Robert G. Miller πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 1 views
Diagnostic difficulties in myasthenia gr
✍ John Maher; FranΓ§ois Grand'maison; Michael W. Nicolle; Michael J. Strong; Charle πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

Four patients with myasthenia gravis presented with severe, largely isolated, bulbar and respiratory muscles weakness. Tensilon tests were positive and antiacetylcholine receptor (anti-AChR) antibody titers were negative in all patients. Only 1 patient had a greater than 10% decremental response dur

Pupillary dysfunction in myasthenia grav
✍ Frederick E. Lepore; George E. Sanborn; Dr John T. Slevin πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 464 KB πŸ‘ 2 views

## Abstract The constriction‐dilation cycles of pupils exposed to a stationary, discrete slit‐lamp beam were significantly prolonged in 25 myasthenic patients (1,060.4 Β± 45.8 msec) undergoing therapy with steroids, anticholinesterases, or both, compared to normal controls (801.9 Β± 8.6 msec) or subj

Thymic lymphocytes in myasthenia gravis
✍ Dr. Gary Birnbaum; Peter Tsairis πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 239 KB πŸ‘ 1 views

## Abstract Lymphocytes from the thymus glands of myasthenic patients and controls were characterized in terms of their percentages of B‐ and T‐cells and their ability to stimulate the proliferation of autologous peripheral blood lymphocytes. Percentages of B‐ and T‐cells were the same in the thymu

Immunoglobulin treatment in refractory m
✍ Anat Achiron; Yoram Barak; Shmuel Miron; Ida Sarova-Pinhas πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 1 views

Failure to induce and maintain remission in severe exacerbations of myasthenia gravis (MG), despite optimal care, is a common problem. We evaluated the efficacy and safety of high-dose intravenous immunoglobulin (IVIg) therapy in an open-label study of 10 patients with severe generalized myasthenia

Targeting T cells in myasthenia gravis
✍ Daniel B. Drachman πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views